Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 16, 2017
First in human evaluation of the vascular biocompatibility and biomechanical performance of a novel ultra high molecular weight amorphous PLLA bioresorbable scaffold in the absence of anti-proliferative drugs: Two-year imaging results in humansMiguel Moncada, Juan A Delgado, Antonio Colombo, et al.
Sensors (Basel, Switzerland)|January 27, 2021
Numerical Study of the Coupling of Sub-Terahertz Radiation to n-Channel Strained-Silicon MODFETsJaime Calvo-Gallego, Juan A Delgado-Notario, Jesús E Velázquez-Pérez, et al.
Cirugia Y Cirujanos|August 5, 2021
Coriocarcinoma de placenta metastásico en embarazo de 34 semanas. Revisión y manejoBlanca Moreno-Gomez, Jesús Castillo-Aznar, Patricia Tejedor-Vargas, et al.
Coronary Artery Disease|November 24, 2016
Three-month evaluation of strut healing using a novel optical coherence tomography analytical method following bioresorbable polymer everolimus-eluting stent implantation in humans: the TIMELESS studyBoris Vesga, Hector Hernandez, Miguel Moncada, et al.
Open Heart|July 5, 2017
Biological effect of microengineered grooved stents on strut healing: a randomised OCT-based comparative study in humansBoris Vesga, Hector Hernandez, Sergio Higuera, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 16, 2011
First clinical evaluation of a luminal self-expanding shield in patients with intermediate coronary lesionsJuan F Granada, Krzysztof Milewski, Maria P Uribe, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 10, 2020
First-in-human evaluation of a novel sirolimus-eluting ultra-high molecular weight APTITUDE bioresorbable scaffold: 9- and 24-month imaging and clinical results of the RENASCENT II trialAlaide Chieffo, Saud Ahmed Khawaja, Azeem Latib, et al.
NPJ Cardiovascular Health|March 26, 2026
Assessing the feasibility of using smartphone data to identify risk of idiopathic pulmonary arterial hypertensionJuan A Delgado-SanMartin, Merve Keles, Niamh Errington, et al.
ACS Nano|July 21, 2025
Unveiling the Miniband Structure of Graphene Moiré Superlattices via Gate-Dependent Terahertz Photocurrent SpectroscopyJuan A Delgado-Notario, Stephen R Power, Wojciech Knap, et al.
Journal of the American College of Cardiology|March 19, 2013
Safety and feasibility of robotic percutaneous coronary intervention: PRECISE (Percutaneous Robotically-Enhanced Coronary Intervention) StudyGiora Weisz, D Christopher Metzger, Ronald P Caputo, et al.
Pageof 4